This supports a “two-hit” model: Phb2 deficiency induces mTOR hyperactivity, but requires OMA1-dependent mitochondrial disruption, as evidenced by the quantified loss of cristae structure, to precipitate severe podocyte injury and FSGS. Here, PHB2 is linked to focal segmental glomerulosclerosis.